ECZEMA ATOPIC DERMATITIS
Clinical trials for ECZEMA ATOPIC DERMATITIS explained in plain language.
Never miss a new study
Get alerted when new ECZEMA ATOPIC DERMATITIS trials appear
Sign up with your email to follow new studies for ECZEMA ATOPIC DERMATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug camoteskimab tested for Tough-to-Treat eczema
Disease control CompletedThis study tested a new drug, camoteskimab, in 62 adults with moderate to severe eczema (atopic dermatitis). Participants received either the drug or a placebo for 16 weeks, followed by an open-label extension where everyone could get the drug. The main goal was to see if camotes…
Matched conditions: ECZEMA ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Apollo Therapeutics Ltd • Aim: Disease control
Last updated Jun 26, 2026 17:44 UTC
-
New eczema drug shows promise in early trial
Symptom relief CompletedThis study tested an experimental drug, EVO301, in 71 adults with moderate-to-severe atopic dermatitis (eczema). The goal was to see if it safely reduces skin redness, thickness, and itch. Participants received either EVO301 or a placebo, and doctors measured changes in skin seve…
Matched conditions: ECZEMA ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Evommune, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
AI boosts doctor accuracy for rare skin diseases in new study
Knowledge-focused CompletedThis study tested whether an artificial intelligence (AI) tool could help doctors diagnose rare and tricky skin conditions like generalized pustular psoriasis (GPP). Fifteen doctors, including both general practitioners and dermatologists, looked at 100 skin images. They first ga…
Matched conditions: ECZEMA ATOPIC DERMATITIS
Sponsor: AI Labs Group S.L • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC